文献速递糖尿病

初发2型糖尿病中的维生素B12与叶酸浓度及二甲双胍治疗的影响

Vitamin B12 and Folate Concentrations in Recent-onset Type 2 Diabetes and the Effect of Metformin Treatment.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本研究基于德国糖尿病研究横断面分析,比较二甲双胍单药治疗(MET,n=123)与非药物治疗(NPT,n=126)的初发2型糖尿病患者(病程<12个月)。结果显示两组血清全转钴胺素(holoTC)和叶酸浓度相似,二甲双胍不影响循环holoTC和叶酸浓度,至少在诊断或起始二甲双胍后前6个月内无需监测维生素B12和叶酸。

要点

  • 二甲双胍单药治疗组与非药物治疗组的holoTC和叶酸浓度相似。
  • 总体holoTC与空腹或葡萄糖刺激的β细胞功能及胰岛素刺激的葡萄糖处置无关。
  • 在非药物治疗组中,叶酸水平与HOMA-IR呈负相关(r=-0.239,P=.007),但二甲双胍组无此关联。

核心结论

  • 二甲双胍不影响初发2型糖尿病患者的循环holoTC和叶酸浓度,至少在诊断或起始二甲双胍后前6个月内无需监测维生素B12和叶酸。

研究设计与样本

  • 德国糖尿病研究中的横断面分析,纳入病程<12个月的2型糖尿病患者,二甲双胍单药治疗组(MET,n=123,81名男性,53±12岁)与非药物治疗组(NPT,n=126,77名男性,54±11岁)。

主要发现

  • holoTC浓度在MET组为105.4 [82.4, 128.3] pmol/L,在NPT组为97 [79.7, 121.9] pmol/L,两组相似。
  • 叶酸浓度在MET组为13.4 [9.3, 19.3] nmol/L,在NPT组为12.7 [9.3, 22.0] nmol/L,两组相似。
  • 总体holoTC与空腹或葡萄糖刺激的β细胞功能及胰岛素刺激的葡萄糖处置无关。
  • 在NPT组但非MET组,叶酸水平与HOMA-IR呈负相关(r=-0.239,P=.007)。
  • 在校正年龄、体重指数和性别后,叶酸水平在整个队列及各组中均与胰岛素敏感性或胰岛素分泌无关。

临床怎么用

  • 作者结论认为,至少在诊断或起始二甲双胍后前6个月内,监测维生素B12和叶酸可省略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Vitamin B12 and folate deficiency are not only linked to hematological, neurological, and cardiovascular diseases, but are also associated with insulin resistance. Metformin can decrease vitamin B12 and folate concentrations. OBJECTIVE: To examine (1) effects of short-term metformin treatment on serum holotranscobalamin (holoTC) and folate and (2) their association with insulin sensitivity in recent-onset type 2 diabetes. DESIGN: This cross-sectional analysis comprised patients (known disease duration <12 months) on metformin monotherapy (MET, n = 123, 81 males, 53 ± 12 years) or nonpharmacological treatment (NPT, n = 126, 77 males, 54 ± 11 years) of the German Diabetes Study. MAIN OUTCOME MEASURES: HoloTC (enzyme-linked immunosorbent assay), cobalamin, and folate (electrochemiluminescence); beta-cell function and whole-body insulin sensitivity, measured during fasting (HOMA-B, HOMA-IR) and intravenous glucose tolerance tests combined with hyperinsulinemic-euglycemic clamp tests. RESULTS: HoloTC (105.4 [82.4, 128.3] vs 97 [79.7, 121.9] pmol/L) and folate concentrations (13.4 [9.3, 19.3] vs 12.7 [9.3, 22.0] nmol/L) were similar in both groups. Overall, holoTC was not associated with fasting or glucose-stimulated beta-cell function and insulin-stimulated glucose disposal. Cobalamin measurements yielded similar results in representative subgroups. In NPT but not MET, folate levels were inversely correlated with HOMA-IR (r = -0.239, P = .007). Folate levels did not relate to insulin sensitivity or insulin secretion in the whole cohort and in each group separately after adjustment for age, body mass index, and sex. CONCLUSIONS: Metformin does not affect circulating holoTC and folate concentrations in recent-onset type 2 diabetes, rendering monitoring of vitamin B12 and folate dispensable, at least during the first 6 months after diagnosis or initiation of metformin.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kanti G, Anadol-Schmitz E, Bobrov P, et al. Vitamin B12 and Folate Concentrations in Recent-onset Type 2 Diabetes and the Effect of Metformin Treatment. J Clin Endocrinol Metab. 2020. PMID: 32219330. doi:10.1210/clinem/dgaa150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。